ImmunogenX is a company developing a therapy for individuals with celiac disease. It also provides a diagnostic tool using a metabolic marker compound that measures the state of recovery of a celiac patient undergoing gluten-free diet treatment. Additionally, the company is engaged in research focused on gluten toxic peptide epitopes in wheat, barley, and rye.
ImmunogenX was founded in 2013

Viewing summary data as a guest

Sign up for free to see all data

ImmunogenX Financials and Metrics

Summary Metrics

Founding Date


ImmunogenX Online and Social Media Presence

Embed Graph

ImmunogenX Frequently Asked Questions

  • When was ImmunogenX founded?

    ImmunogenX was founded in 2013.

  • Who are ImmunogenX competitors?

    Competitors of ImmunogenX include SleepEffect Center for Apnea Management, Stago and Xcelris.